Chitosan-modified nanocarriers as carriers for anticancer drug delivery: Promises and hurdles
Authors:
- Fahad Saad AlhodiebFAFahad Saad Alhodieb
- Abul BarkatABAbul Barkat
- Harshita Abul BarkatHBHarshita Abul Barkat
- Hazrina Ab HadiHazrina Ab Hadi
- Muhammad Idreesh KhanMKMuhammad Idreesh Khan
- Fauzia AshfaqFAFauzia Ashfaq
- Mohammad Akhlaquer RahmanMRMohammad Akhlaquer Rahman
- Mohd. Zaheen HassanMHMohd. Zaheen Hassan
- Abdulkareem A. AlaneziAAAbdulkareem A. Alanezi
- 5 July 2022
- journal article
- review article
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 217, 457-469
Abstract
No abstract availableKeywords
Funding Information
- Qassim University
This publication has 93 references indexed in Scilit:
- 5-aminolevulinic acid-incorporated nanoparticles of methoxy poly(ethylene glycol)-chitosan copolymer for photodynamic therapyInternational Journal of Nanomedicine, 2013
- Enhanced Oral Delivery of Docetaxel Using Thiolated Chitosan Nanoparticles: Preparation, In Vitro and In Vivo StudiesBioMed Research International, 2013
- Biocompatibility of Chitosan Carriers with Application in Drug DeliveryJournal of Functional Biomaterials, 2012
- Targeted therapy for cancer using pH-responsive nanocarrier systemsLife Sciences, 2012
- Biodegradable nanoparticles are excellent vehicle for site directed in-vivo delivery of drugs and vaccinesJournal of Nanobiotechnology, 2011
- Chlorotoxin Labeled Magnetic Nanovectors for Targeted Gene Delivery to GliomaACS Nano, 2010
- Chitosan Based Polyelectrolyte Complexes as Potential Carrier Materials in Drug Delivery SystemsMarine Drugs, 2010
- A stimulus-responsive magnetic nanoparticle drug carrier: Magnetite encapsulated by chitosan-grafted-copolymerActa Biomaterialia, 2008
- In vitro and in vivo suppression of hepatocellular carcinoma growth by chitosan nanoparticlesEuropean Journal of Cancer, 2007
- Targeting death and decoy receptors of the tumour-necrosis factor superfamilyNature Reviews Cancer, 2002